PARAMEDIC2 试验中肾上腺素给药时机的影响
该研究基于 PARAMEDIC2 随机对照试验,纳入英格兰和威尔士 5 家 NHS 救护服务中初始复苏无反应且为目击性院外心脏骤停的患者,随机接受 1 mg 静脉肾上腺素或匹配安慰剂。共 8016 例入组,其中目击性心脏骤停 4902 例(安慰剂组 2437 例,肾上腺素组 2465 例)。随时间延长,两组自主循环恢复几率均下降,但安慰剂组下降更快(OR 0.93,95%CI 0.92-0.95),肾上腺素组为 OR 0.96(95%CI 0.95-0.97),交互作用 OR 1.03(95%CI 1.01-1.05,P=0.005)。生存率和良好神经功能结局随时间延长而下降,但两组间无差异。结论:随时间延长,肾上腺素增加自主循环恢复机会,但未影响远期结局。
要点
- 目击性院外心脏骤停患者中,随给药时间延长,自主循环恢复几率在安慰剂组下降更快(OR 0.93,95%CI 0.92-0.95),肾上腺素组为 OR 0.96(95%CI 0.95-0.97),交互作用 P=0.005。
- 随时间延长,生存率和良好神经功能结局均下降,但肾上腺素组与安慰剂组之间无差异。
- 肾上腺素增加自主循环恢复机会的作用随给药时间延长而相对增大,但远期结局不受给药时机影响。
- 研究纳入初始复苏无反应的目击性院外心脏骤停患者,随机接受 1 mg 静脉肾上腺素或匹配安慰剂。
适用人群与场景
- 英格兰和威尔士 5 家 NHS 救护服务中,初始复苏尝试无反应的目击性院外心脏骤停患者。
- 随机分组时间为 2014 年 12 月至 2017 年 10 月。
处置流程与药物剂量
- 随机接受 1 mg 静脉肾上腺素或匹配安慰剂,治疗包除治疗编号外完全相同。
- 参与者和研究工作人员对治疗分配设盲。
研究设计与关键结果
- PARAMEDIC2 随机对照试验,共入组 8016 例,其中目击性心脏骤停 4902 例,安慰剂组 2437 例,肾上腺素组 2465 例。
- 自主循环恢复几率随时间下降,安慰剂组 OR 0.93(95%CI 0.92-0.95),肾上腺素组 OR 0.96(95%CI 0.95-0.97),交互作用 OR 1.03(95%CI 1.01-1.05,P=0.005)。
- 生存率和良好神经功能结局随时间延长而下降,但肾上腺素组与安慰剂组之间无差异。
证据类型、等级与局限
- 证据类型:随机对照试验(PARAMEDIC2)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,随给药时间延长,肾上腺素增加自主循环恢复的机会,但远期结局不受肾上腺素给药时机影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To examine the time to drug administration in patients with a witnessed cardiac arrest enrolled in the Pre-Hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug Administration in Cardiac Arrest (PARAMEDIC2) randomised controlled trial.
METHODS: The PARAMEDIC2 trial was undertaken across 5 NHS ambulance services in England and Wales with randomisation between December 2014 and October 2017. Patients with an out-of-hospital cardiac arrest who were unresponsive to initial resuscitation attempts were randomly assigned to 1 mg intravenous adrenaline or matching placebo according to treatment packs that were identical apart from treatment number. Participants and study staff were masked to treatment allocation.
RESULTS: 8016 patients were enrolled, 4902 sustained a witnessed cardiac arrest of whom 2437 received placebo and 2465 received adrenaline. The odds of return of spontaneous circulation decreased in both groups over time but at a greater rate in the placebo arm odds ratio (OR) 0.93 (95% CI 0.92-0.95) compared with the adrenaline arm OR 0.96 (95% CI 0.95-0.97); interaction OR: 1.03, 95% CI 1.01-1.05, p = 0.005. By contrast, although the rate of survival and favourable neurological outcome decreased as time to treatment increased, the rates did not differ between the adrenaline and placebo groups.
CONCLUSION: The rate of return of spontaneous circulation, survival and favourable neurological outcomes decrease over time. As time to drug treatment increases, adrenaline increases the chances of return of spontaneous circulation. Longer term outcomes were not affected by the time to adrenaline administration. (ISRCTN73485024).
参考来源
- Perkins GD, Kenna C, Ji C, et al. The influence of time to adrenaline administration in the Paramedic 2 randomised controlled trial. Intensive Care Med. 2020. PMID: 31912202. doi:10.1007/s00134-019-05836-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。